{"version":"1.0","type":"link","title":"Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD study.","author_name":"Trotman J 외","author_url":"https://prs-insight.online/author/Trotman%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/159168","thumbnail_width":1200,"thumbnail_height":630}